Stem Cells in MDR-TB and XDR - TB

By  

Current Respiratory Medicine Reviews, Vol. 10, Iss. 4, 2015-05 ,pp. : 238-240

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the Human Macrophage with Combinations of Drugs and Inhibitors of Ca2+ and K+ Transport to Enhance the Killing of Intracellular Multi-Drug Resistant Mycobacterium tuberculosis (MDR-TB) - a Novel, Patentable Approach to Limit the Emergence of XDR-TB

By  

Recent Patents on Anti-Infective Drug Discovery, Vol. 6, Iss. 2, 2011-05 ,pp. : 110-117

Bentham Science Publishers

Access to resources Recommend Favorite

High-dose fluoroquinolones in short-course regimens for treatment of MDR-TB: the way forward? [Editorial]

By Yew Wing-Wai  

The International Journal of Tuberculosis and Lung Disease, Vol. 17, Iss. 7, 2013-07 ,pp. : 853-854

International Union Against Tuberculosis and Lung Disease

Access to resources Recommend Favorite

Safety and Efficacy of Thioridazine as Salvage Therapy in Indian Patients with XDR-TB

By  

Recent Patents on Anti-Infective Drug Discovery, Vol. 6, Iss. 2, 2011-05 ,pp. : 88-91

Bentham Science Publishers

Access to resources Recommend Favorite

XDR-TB, What is it; How is it Treated; and why is Therapeutic Failure so High?

By  

Recent Patents on Anti-Infective Drug Discovery, Vol. 6, Iss. 2, 2011-05 ,pp. : 77-83

Bentham Science Publishers

Access to resources Recommend Favorite